The development of methods for obtaining monoclonal antibody-producing cells
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2016, Vol 70, Issue
Abstract
Monoclonal antibodies (mAbs) are biomolecules of great scientific and practical significance. In contrast to polyclonal antibodies from immune sera, they are homogeneous and monospecific, since they are produced by hybridoma cells representing a clone arising from a single cell. The successful technology was described for the first time in 1975; the inventors were later awarded the Nobel Prize. Currently, mAbs are broadly used as a research tool, in diagnostics and medicine in particular for the treatment of cancer or in transplantology. About 47 therapeutics based on monoclonal antibodies are now available in the US and Europe, and the number is still growing. Production of monoclonal antibodies is a multistage, time-consuming and costly process. Growing demand for these molecules creates space for research focused on improvements in hybridoma technology. Lower costs, human labor, and time are important goals of these attempts. In this article, a brief review of current methods and their advances is given.
Authors and Affiliations
Michał Skowicki, Tomasz Lipiński
Keywords
Related Articles
- EP ID EP220660
- DOI -
- Views 182
- Downloads 0
Heart rate variability after BRL37344, a beta-3 agonist, in experimental bladder outlet obstruction
Introduction: Bladder overactivity symptoms accompany benign prostatic hyperplasia (BPH) syndrome. The autonomic nervous system (ANS) disturbances may be involved in bladder dysfunction. An ameliorating effect on bladder...
Immunostymulujące właściwości preparatów pozyskiwanych z jemioły i ich zastosowanie w onkologii
Przez długi czas immunoterapia onkologiczna była w cieniu chemio- i radioterapii. Dopiero niedawno analitycy tygodnika naukowego Science doszli do wniosku, że wykorzystanie układu odpornościowego człowieka do walki z rak...
Związek wybranych polimorfizmów genów z metabolizmem statyn, ryzykiem udaru niedokrwiennego mózgu i chorób sercowo-naczyniowych
Histone deacetylase inhibitors – molecular mechanisms of actions and clinical applications
Histone deacetylases (HDACs) play an important role in the epigenetic regulation of gene expression implicated in cancer pathogenesis. Inhibitors of HDACs (HDI) are under investigation as novel anti-cancer drugs, which i...
Rola mechanizmów buforowania lęku u nosicieli wirusa HIV. Badanie w paradygmacie Teorii Opanowywania Trwogi
Wprowadzenie: Praca dotyczy problemu określenia poziomu wzrostu posttraumatycznego (posttraumatic growth – PTG), czyli psychologicznego mechanizmu adaptacyjnego występującego po doświadczeniu skrajnych przeżyć życiowych...